MAPK8 and neoplasm: During HCV-related carcinogenesis, JNK-activated chronic inflammation confers a selective advantage on preneoplastic hepatocytes by shifting Smad3 signaling from the tumor-suppressive pSmad3C to the oncogenic pSmad3L pathway (27).